Clinical Trial Update: Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy, safety, and cost-efficacy of a pre-emptive genotyping strategy in patients receiving statins.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Dyslipidemias

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Cardiovascular Diseases, Dyslipidemias | Phase 4 | Status: UNKNOWN